Logo image of AVTR

AVANTOR INC (AVTR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AVTR - US05352A1007 - Common Stock

11.17 USD
-0.3 (-2.62%)
Last: 12/12/2025, 8:14:58 PM
11.17 USD
0 (0%)
After Hours: 12/12/2025, 8:14:58 PM
Fundamental Rating

4

Overall AVTR gets a fundamental rating of 4 out of 10. We evaluated AVTR against 57 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of AVTR while its profitability can be described as average. AVTR is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AVTR had positive earnings in the past year.
In the past year AVTR had a positive cash flow from operations.
Each year in the past 5 years AVTR has been profitable.
In the past 5 years AVTR always reported a positive cash flow from operatings.
AVTR Yearly Net Income VS EBIT VS OCF VS FCFAVTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

AVTR's Return On Assets of -0.70% is fine compared to the rest of the industry. AVTR outperforms 61.40% of its industry peers.
AVTR's Return On Equity of -1.48% is fine compared to the rest of the industry. AVTR outperforms 61.40% of its industry peers.
The Return On Invested Capital of AVTR (4.80%) is better than 70.18% of its industry peers.
AVTR had an Average Return On Invested Capital over the past 3 years of 6.58%. This is significantly below the industry average of 13.99%.
Industry RankSector Rank
ROA -0.7%
ROE -1.48%
ROIC 4.8%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
AVTR Yearly ROA, ROE, ROICAVTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

AVTR's Profit Margin has improved in the last couple of years.
AVTR has a better Operating Margin (9.18%) than 68.42% of its industry peers.
In the last couple of years the Operating Margin of AVTR has grown nicely.
AVTR has a worse Gross Margin (33.13%) than 64.91% of its industry peers.
In the last couple of years the Gross Margin of AVTR has remained more or less at the same level.
Industry RankSector Rank
OM 9.18%
PM (TTM) N/A
GM 33.13%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
AVTR Yearly Profit, Operating, Gross MarginsAVTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AVTR is destroying value.
The number of shares outstanding for AVTR has been increased compared to 1 year ago.
The number of shares outstanding for AVTR has been increased compared to 5 years ago.
AVTR has a better debt/assets ratio than last year.
AVTR Yearly Shares OutstandingAVTR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AVTR Yearly Total Debt VS Total AssetsAVTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

AVTR has an Altman-Z score of 1.77. This is a bad value and indicates that AVTR is not financially healthy and even has some risk of bankruptcy.
AVTR has a Altman-Z score (1.77) which is in line with its industry peers.
AVTR has a debt to FCF ratio of 7.37. This is a slightly negative value and a sign of low solvency as AVTR would need 7.37 years to pay back of all of its debts.
AVTR has a better Debt to FCF ratio (7.37) than 61.40% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that AVTR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, AVTR is not doing good in the industry: 71.93% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 7.37
Altman-Z 1.77
ROIC/WACC0.49
WACC9.73%
AVTR Yearly LT Debt VS Equity VS FCFAVTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.49 indicates that AVTR should not have too much problems paying its short term obligations.
AVTR has a worse Current ratio (1.49) than 77.19% of its industry peers.
AVTR has a Quick Ratio of 1.49. This is a bad value and indicates that AVTR is not financially healthy enough and could expect problems in meeting its short term obligations.
AVTR has a worse Quick ratio (0.96) than 82.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.96
AVTR Yearly Current Assets VS Current LiabilitesAVTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The earnings per share for AVTR have decreased by -2.04% in the last year.
The earnings per share for AVTR have been decreasing by -10.82% on average. This is quite bad
The Revenue has decreased by -3.59% in the past year.
Measured over the past years, AVTR shows a small growth in Revenue. The Revenue has been growing by 2.35% on average per year.
EPS 1Y (TTM)-2.04%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)-3.59%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-5.28%

3.2 Future

Based on estimates for the next years, AVTR will show a small growth in Earnings Per Share. The EPS will grow by 5.40% on average per year.
The Revenue is expected to grow by 1.67% on average over the next years.
EPS Next Y-8.14%
EPS Next 2Y-3.98%
EPS Next 3Y1.33%
EPS Next 5Y5.4%
Revenue Next Year-4.16%
Revenue Next 2Y-2.02%
Revenue Next 3Y-0.12%
Revenue Next 5Y1.67%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AVTR Yearly Revenue VS EstimatesAVTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
AVTR Yearly EPS VS EstimatesAVTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1

7

4. Valuation

4.1 Price/Earnings Ratio

AVTR is valuated reasonably with a Price/Earnings ratio of 11.64.
AVTR's Price/Earnings ratio is rather cheap when compared to the industry. AVTR is cheaper than 98.25% of the companies in the same industry.
When comparing the Price/Earnings ratio of AVTR to the average of the S&P500 Index (26.54), we can say AVTR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 12.11, the valuation of AVTR can be described as correct.
98.25% of the companies in the same industry are more expensive than AVTR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.78. AVTR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 11.64
Fwd PE 12.11
AVTR Price Earnings VS Forward Price EarningsAVTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVTR is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AVTR indicates a rather cheap valuation: AVTR is cheaper than 94.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.55
EV/EBITDA 11.29
AVTR Per share dataAVTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of AVTR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.98%
EPS Next 3Y1.33%

0

5. Dividend

5.1 Amount

AVTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AVANTOR INC

NYSE:AVTR (12/12/2025, 8:14:58 PM)

After market: 11.17 0 (0%)

11.17

-0.3 (-2.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-05 2026-02-05/amc
Inst Owners100.14%
Inst Owner Change-5.16%
Ins Owners0.3%
Ins Owner Change6.07%
Market Cap7.62B
Revenue(TTM)6.58B
Net Income(TTM)-82.20M
Analysts70.77
Price Target13.84 (23.9%)
Short Float %3.89%
Short Ratio2.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.53%
Min EPS beat(2)-5.09%
Max EPS beat(2)-3.97%
EPS beat(4)1
Avg EPS beat(4)-2.12%
Min EPS beat(4)-5.09%
Max EPS beat(4)2.94%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)6
Avg EPS beat(12)0.63%
EPS beat(16)9
Avg EPS beat(16)1.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.91%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)-1.44%
Revenue beat(8)0
Avg Revenue beat(8)-2.36%
Revenue beat(12)0
Avg Revenue beat(12)-2.35%
Revenue beat(16)0
Avg Revenue beat(16)-2.39%
PT rev (1m)-5.85%
PT rev (3m)-3.12%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)-15.22%
EPS NY rev (1m)-1.09%
EPS NY rev (3m)-4.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.08%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 11.64
Fwd PE 12.11
P/S 1.16
P/FCF 14.55
P/OCF 11.82
P/B 1.37
P/tB N/A
EV/EBITDA 11.29
EPS(TTM)0.96
EY8.59%
EPS(NY)0.92
Fwd EY8.25%
FCF(TTM)0.77
FCFY6.88%
OCF(TTM)0.95
OCFY8.46%
SpS9.64
BVpS8.17
TBVpS-3.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.28
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -1.48%
ROCE 5.94%
ROIC 4.8%
ROICexc 4.92%
ROICexgc 29.45%
OM 9.18%
PM (TTM) N/A
GM 33.13%
FCFM 7.96%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
ROICexc(3y)6.76%
ROICexc(5y)6.74%
ROICexgc(3y)52.77%
ROICexgc(5y)49.06%
ROCE(3y)8.14%
ROCE(5y)8.11%
ROICexgc growth 3Y9.06%
ROICexgc growth 5Y15.03%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y1.59%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 7.37
Debt/EBITDA 3.6
Cap/Depr 29.62%
Cap/Sales 1.84%
Interest Coverage 3.73
Cash Conversion 63.69%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 0.96
Altman-Z 1.77
F-Score5
WACC9.73%
ROIC/WACC0.49
Cap/Depr(3y)35.33%
Cap/Depr(5y)30.17%
Cap/Sales(3y)2.02%
Cap/Sales(5y)1.71%
Profit Quality(3y)143.28%
Profit Quality(5y)453.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.04%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y-8.14%
EPS Next 2Y-3.98%
EPS Next 3Y1.33%
EPS Next 5Y5.4%
Revenue 1Y (TTM)-3.59%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-5.28%
Revenue Next Year-4.16%
Revenue Next 2Y-2.02%
Revenue Next 3Y-0.12%
Revenue Next 5Y1.67%
EBIT growth 1Y-4.14%
EBIT growth 3Y-9.65%
EBIT growth 5Y4.59%
EBIT Next Year2.52%
EBIT Next 3Y1.39%
EBIT Next 5Y3.54%
FCF growth 1Y-24.62%
FCF growth 3Y-6.35%
FCF growth 5Y18.01%
OCF growth 1Y-21.8%
OCF growth 3Y-4.11%
OCF growth 5Y18.89%

AVANTOR INC / AVTR FAQ

What is the ChartMill fundamental rating of AVANTOR INC (AVTR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AVTR.


Can you provide the valuation status for AVANTOR INC?

ChartMill assigns a valuation rating of 7 / 10 to AVANTOR INC (AVTR). This can be considered as Undervalued.


How profitable is AVANTOR INC (AVTR) stock?

AVANTOR INC (AVTR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AVTR stock?

The Price/Earnings (PE) ratio for AVANTOR INC (AVTR) is 11.64 and the Price/Book (PB) ratio is 1.37.


Can you provide the financial health for AVTR stock?

The financial health rating of AVANTOR INC (AVTR) is 2 / 10.